Novartis AG (BCBA:NVS)

Market Cap	360.85T
Revenue (ttm)	65.77T
Net Income (ttm)	16.27T
Shares Out	n/a
EPS (ttm)	8,163.07
PE Ratio	22.18
Forward PE	14.91
Dividend	624.65 (1.22%)
Ex-Dividend Date	Mar 12, 2025

Volume	946
Average Volume	283
Open	51,350
Previous Close	51,375
Day's Range	48,660 - 51,350
52-Week Range	26,525 - 51,950
Beta	n/a
RSI	53.61
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD